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Abstract 
Theoretical arguments and some mathematical models of host-parasite 
coevolution (e.g. [1- 6]) suggest host immunity as the driving source for the 
evolution of parasite virulence. Imperfect vaccines in particular, can play the role 
and recent work [7] sets to test these ideas experimentally, using the mouse 
malaria model, Plasmodium chabaudi. To this end the authors evolve parasite 
lines in immunized and nonimmunized (“naïve”) mice using serial passage of 
infected blood samples. They find parasite lines evolved in immunized mice 
become more virulent than those evolved in naive mice. Furthermore, this feature 
persisted even when the evolved strains were transmitted through mosquitoes.  
Here we develop a mathematical model of parasite dynamics that 
qualitatively reproduces the experimental results of [7]. Our model accounts for 
the basic in-host processes: (i) production and depletion of red blood cells (RBC); 
(ii) immune-modulated parasite growth/ replication, (iii) immune stimulation and 
clearing of parasite. Besides we introduce multiple parasite strains with variable 
levels of virulence, and allow random mutations during replication process. The 
virulence is represented by a single parameter – immune stimulation threshold. So 
more virulent strains have higher “tolerance levels”, hence increased RBC 
depletion (anemia).  
Numeric simulations with our model exhibit, as in [7] the overall 
evolution of virulence in serial passage of parasite strains, and its enhancement 
through partial (imperfect) immunization. 
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I. Introduction 
 Malaria is a mosquito-borne infection transmitted by Plasmodium protozoa. Four species of 
parasite (P. falciparum, P. vivax, P. ovale and P malariae) are known to infect humans, and there 
are similar types infecting other mammalian hosts. The parasites are transmitted by infected 
Anopheles mosquitoes that acquire infection by feeding on blood from infected hosts. The clinical 
symptoms of malaria include fever, chills, pain, and sweats, which develop 7-14 days after the bite 
of an infectious mosquito. The duration and severity of disease may vary, depending on many 
factors such as intensity of infection, biology of the host, its immune status et al.  
 The parasite has two distinct phases of reproduction: a sexual (gametocyte-mating) stage in 
the mosquito, and an asexual phase in mammalian hosts, where it undergoes several stages and 
patterns of replication. Initially, in human/ mammalian infection, a sporozoite carried in the insect 
saliva enters the blood stream, migrates to liver, and invades liver cells. After a 7-day period, it 
releases large number (10,000-30,000) of short-lived but extracellular blood stages, called 
merozoites. The merozoites rapidly invade red blood cells (RBC) and turn into trophozoites. Inside 
the RBC they undergo asexual replication over a 48-72 hr period (depending on species), then 
bursts the cell, releasing a dozen of new merozoites to continue the cycle. This exponential parasite 
growth, associated with cyclical episodes of hemolysis, is mostly responsible for the clinical 
symptoms of malaria.  
Concurrent with parasite growth the host develops immunity (innate and specific responses) 
that allows it to control parasitaemia, and under suitable conditions eliminate it altogether. As many 
other parasites Plasmodium has adopted various mechanism of immune evasion, including genetic 
mutations on each replication cycle. The resulting diversification into multiple parasite strains, and 
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selective pressures (e.g. immunity or drug treatment) can gradual evolve such features as drug 
resistance or virulence. 
Here we set up a mathematic model of in-host RBC-parasite dynamics for single and multi 
strains to explore the evolution of virulence through selective immune pressure, suggested by 
theoretical studies [1-6] and experimental work [7]. Our model utilizes some features of continuous 
in-host models (e.g. [8-11]), as well as discrete and stochastic ones [12-13]. We implanted it on 
Wolfram Mathematica 5 package, and conducted a series of numeric experiments that corroborate 
the basic conclusions of earlier theoretical and experimental work. 
II. Methods: Stochastic model of in-host dynamics for single and multiple P. 
strains. 
 The state of the system at discrete time 1,2,...t =  is described by (non-infected) RBC 
density tN  (per lμ  of blood), parasite densities: tY  - young stage (newly infected iRBC), tX  - old 
stage/ schizont, and the immune effector variable tJ . The system below incorporates the following 
basic processes: 
• RBC production and removal through natural death and infection 
• Merozoite release and invasion of un-infected RBC 
• iRBC survival in a given immune environment J  
• immune stimulations by the young and old stages Y, X 
Besides for multiple strains, designated by { }, ; 1,2,...i iY X i =  of different virulence types we 
allow random (genetic) transitions on each time step = ½ replication cycle, from type j to i with 
prescribed probabilities 0; 1ij ij
i
a a⎧ ⎫≥ =⎨ ⎬⎩ ⎭∑ .  
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 Production. For RBC production/loss we take a finite-difference equation 
 N N N1
production loss infectious removal
t t tN N Yα β+ = + −  (1) 
with constant production rate 45 10 / dayα = ⋅ , natural loss .99β =  (for 100 day life span for RBC), 
based on equilibrium RBC level 60 5 10 /1
N lα μβ= ≈ ⋅− . The production term could be made to 
depend on RBC-deficit (relative to ‘norm’) ( )01 /N Nα − , - enhanced RBC production.  
 Invasion. Released merozoites, trX  (with replication number 8r =  per schizont) compete 
for the available RBC population N. We assume the maximal number of potential invasions 
depends on rX and N as 
 ( ),t tt
t t
rX NC rX N
rX N
φ⋅= =+ , where ( ),
xyx y
x y
φ = +  (2) 
Such function φ  has the property that C rX≈  - for small rX, but saturates at value C N≈ , as rX 
increases (as the number of successful invasions should not exceed the total available RBCs). Each 
potential invading merozoite can succeed with a (density-dependent) probability 
 ( ) ( )0
1,
1 /t t t t t
p p rX N
rX N x
= = +  (3) 
Such p drops to 1/2, when the relative density /rX N  (‘merozoites’ over ‘RBCs’) reaches threshold 
0x .  The combined effect of C potential merozoites having probability of invasion p is given by the 
binomial distribution 
 ( )1 Bi |t t tY C p+ =  (4) 
which determines the number of young stages at the next time-step. 
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 Survival. Once invaded, the infected RBC will survive through the old stage (next 
replication cycle) with a probability ( )q J  that depends on the immune environment - the level of J 
effector. We take survival probability  
 ( ) 1
1
q J
J
= +  (5) 
similar to ( )/p rX N  in (3). So the surviving (old-stage) population is given by another binomial 
equation 
 ( )( )1 Bi | /t t tX Y q J V+ =  (6) 
where V designates the strain-specific sensitivity threshold. Higher V means higher likelihood of 
survival in a given J- environment. Threshold V will serve as a marker of virulence. Indeed a 
‘comparison plot’ (Figure 2) shows larger V having higher parasite densities X Y+ , and higher 
anemia rates (RBC-loss). 
 Immune stimulation and loss. The effector variable is stimulated by the combined iRBC 
density, weighted by its immunogenic factors and relative duration of 2 (young-old) stages of 
development, 
 N1
loss
stimulation
2
t t
t t
t
X YJ J
N
σ λ+ ⎛ ⎞+= +⎜ ⎟⎝ ⎠	

 (7) 
Here we assume both stages of equal duration, and ‘stimulation function’ σ  depending on relative 
density ‘iRBC/RBC’. The loss factor .99λ ≈ , corresponds to .01/day loss-rate of immune effector. 
 The result is a discrete time step (1 day) coupled stochastic system (1) -(7) 
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 ( )
( )( )
1
1
1
1
;
Bi | ;
Bi | / ;
2
t t t
t t t
t t t
t t
t t
t
N N Y
Y C p
X Y q J V
X YJ J
N
α β
σ λ
+
+
+
+
= + −
=
=
⎛ ⎞+= +⎜ ⎟⎝ ⎠
 (8) 
for variables { }, , ,N Y X J  (single strain), with functions ( ),C rX N of (2), invasion probability p  
(3), survival probability q  (5), and simulation ( ) 0x s xσ = , taken as a simple linear function. The 
essential parameters of the model are 
RBC production/loss 45 10 ; .99α β= ⋅ =  
Merozoite replication factor 8r =  
Invasion probability threshold 0 .6x =  
Survival probability (virulence) threshold .1 .3V≤ ≤  
Immune stimulation coefficient 0 8s =  
Immune loss rate  .99λ =  
Table 1: Basic in-host parameters 
 Some parameters e.g. ; ;rα β are fixed (known), while others 0 0; ; ;x s Vλ  - can be estimated 
from the experimental lab data. Some of them could be strain and host specific. 
 Multi-strain model. A single-strain system (8) can be extended to a multi-strain one, with 
strains labeled by the genotype index 1,2,...i n= . We assume the released merozoites (on each time 
step) can change their genotypes according to ‘switching (stochastic) matrix’ ijA a⎡ ⎤= ⎣ ⎦ . The 
‘invading crop’ of type i is then given by 
 ;i iij j
j
C a r X Nφ ⎛ ⎞= ⎜ ⎟⎝ ⎠∑  (9) 
with the (density dependent) invasion probability 
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0
1
1 jj
j
i
r X x N
p p= = ⎛ ⎞+ ⎜ ⎟⎝ ⎠∑
 (10) 
and J-dependent survival probability 1
1 /
i
i
q
J V
= +  , each strain having its specific virulence 
threshold iV . All strains stimulate production of immune effector J, either through their individual 
contributions, 
2
j j
j
X Y
N
σ ⎛ ⎞+⎜ ⎟⎝ ⎠∑  (with possibly ‘strain-specific’ functions { }jσ σ= ). Alternatively 
we can take their combined density 
2
j j
j
X Y
N
σ ⎛ ⎞+⎜ ⎟⎝ ⎠∑ , assuming homologous strains. The resulting 
2n+2 system of equations takes the form  
 
( )
( )( )
1
1
1
1
;
Bi | ;
Bi | / ;
2
j
t t t
j
i i
t t t
i i
t t t i
j j
t tj
t t
t
N N Y
Y C p
X Y q J V
X Y
J J
N
α β
σ λ
+
+
+
+
= + −
=
=
⎛ ⎞+⎜ ⎟= +⎜ ⎟⎝ ⎠
∑
∑
 (11) 
Random mutations: In simulations below we use the parameters of Table 1, and tri-
diagonal transition matrix A with entries .99iia = , and , 1 .005i ia ± =  (off-diagonal). So each 
genotype generates 99% of the same type (on each replication cycle), while .5% would ‘up’ or 
‘down’ the ‘geno-scale’. There are many ways to modify such matrix A. 
III. Results: numeric simulations and analysis 
Single strain in a single host over 80-day period. We take system (8) with virulence 
threshold .2V = . Typically we observe parasitemia to reached its peak by day 15, and subside by 
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day 30. The follow-up repeated (damped) cycles are approximately 35 -day long, and anemia (RBC 
depletion) can reach up to 40% of the normal RBC-level. 
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Figure 1: Upper left plot: RBC-level N (thin) and combined Y+X density (thick). Upper right 
plot: effector J (thick curve) and survival probability q(J) –shaded. Bottom plot: iRBC, 
X+Y (black curve), Y (gray) 
 
 Inter-strain comparison. Here we consider 6 virulent strains (in separate hosts), with 
threshold parameter V  varying over the range 0.1 0.3V≤ ≤ . Figure 2 shows several effects of 
higher virulence: increases anemia (from 30% maximal depletion at 0.1V = , to 60% reduction at 
0.3V = ), and enhanced (but delayed) production of the immune effector (right plot).  
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Figure 2: Comparison of 6 virulent strains (fading shades of gray): left plot shows levels of 
RBC (top) and iRBC (bottom); right plot - the corresponding immune effector curves. 
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 Multi-strain in-host competition. Now we allow 8 strains ( 1,2,...8i = ) of increased 
virulence 0.1 0.3iV≤ ≤  described by system (11) to compete within a host over 40-day period. We 
initialize the system with the utmost benign strain ( 1i = ), the mutations matrix A (for each 
replication cycle) will gradually shift it more virulent types.  Four panels of Figure 3 show: i) RBC 
tN  and combined parasitemia ( )
1,...8
i i
t t
i
Y X
=
+∑  (top left), ii) the immune effector (top right); iii) 
Log-parasitemia { }: 1, 2,...i it tY X i+ =  spreading to higher-virulence types (bottom left), and 
distribution of 20-day average parasitemia over strains 1,2,...8i = (bottom right). Only #1 and #2 
maintain substantial levels over 20-day period. Note that the cumulative RBC, parasitemia and 
effector J behave similar to a single-strain case of Figure 1.  
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Figure 3: Evolution of multi-strain infection over 40-day period. 
 
Serial passage experiments. Our next example attempts to replicate the mice experiments 
of [7]. Here infected (multi-strain) blood sample taken at the end of a 20-day run, is transmitted 
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from infected to the next-generation immuno naïve host, and let to run for another 20 days (past the 
upsurge peak). We run a sequence of 16 transmission cycles and follow the evolution of RBC, 
parasitemia (iRBC) and immune effector J (Figure 4). Note that anemia (RBC depletion level) 
increases with each transmission cycle from about 40% to 55%, as more virulent strains take over. 
Figure 5 corroborates this conclusion by showing period average (over 20 days) distribution of 8 
parasite densities, from the first host (top left) to the last (bottom right). One sees clear transition 
from benign strains (host #1) to virulent (#16).  The system seems to stabilize by 12th cycle.  
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Figure 4: RBC and combined parasitemia (top); immune effector (bottom) of a sequence of 
16 immuno-naïve mice, each one subjected to 20-day infectious period 
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Figure 5: Parasitemia profiles on the 8-strain virulence scale (each sample averaged over its 
20-day period), for 16 transmission cycles. Cycle ## proceed in rows from “top-left” to 
“bottom-right”. 
 
Serial passage run with 16 generations of partially vaccinated mice. We repeat the 
above experiment, but now each mouse is given an initial level of immune effector 0 .5J =  (about 
1/5 of the maximal attainable level of J in Figure 5) due to vaccination. In the previous case ‘naïve 
mice’ had 0 0J = . A comparison between 2 cases (Figure 6), shows the gradual increase of anemia 
due to virulence, which reach comparable levels (along with maximal J-levels) by the 9th cycle. 
Although the bottom level anemia (RBC) of vaccinated mice seem to overshoot somewhat the 
‘naïve’ ones at late cycles. More interesting and instructive view of the spread of virulence 
however, is the period-average distribution of parasitemia among 8 strains in two cases (Figure 7). 
For each transmission cycle the ‘naïve distribution’ (red) looks more benign (shifted to the left) 
compared to the ‘vaccinated distribution’ (blue). By late cycle (#11-16) the most virulent strain #8 
takes dominance, furthermore #8 (blue) exceeds the comparable level of #8 (red).  
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Figure 6: Same as Figure 4 for comparison of 16 generations of partially vaccinated mice 
(black) vs. 16 naïve generations (green). 
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Figure 7: Comparison of time-average strain distribution for two cases: naïve (red) vs. 
partially vaccinated (blue). The 16 transmission cycles are ordered as in Figure 5 
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IV. Conclusions  
We develop a mathematical model of multiple competing parasite strains of varying 
virulence subjected to selective immune pressure. Its numeric simulations show how in-host 
competition followed by the serial passage of infection over several generations can shift the strain 
profile towards more virulent pattern. Furthermore, we observe the enhanced evolution of virulence 
when subsequent inocula are given a partial immune protection (immune boost). Our model 
corroborates the earlier experimental conclusions of [7], and pinpoints a plausible mechanism of 
immune selection of virulent strains. 
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